OPC Stock Overview
Engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicines in Vietnam and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
OPC Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫23,450.00 |
| 52 Week High | ₫27,000.00 |
| 52 Week Low | ₫21,550.00 |
| Beta | 0.17 |
| 11 Month Change | -4.29% |
| 3 Month Change | -5.06% |
| 1 Year Change | 0% |
| 33 Year Change | -0.85% |
| 5 Year Change | 15.57% |
| Change since IPO | 123.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| OPC | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -4.3% | -2.7% | -2.9% |
| 1Y | 0% | 11.6% | 2.1% |
Return vs Industry: OPC underperformed the VN Pharmaceuticals industry which returned 11.6% over the past year.
Return vs Market: OPC underperformed the VN Market which returned 2.1% over the past year.
Price Volatility
| OPC volatility | |
|---|---|
| OPC Average Weekly Movement | 4.1% |
| Pharmaceuticals Industry Average Movement | 4.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in VN Market | 7.9% |
| 10% least volatile stocks in VN Market | 2.8% |
Stable Share Price: OPC has not had significant price volatility in the past 3 months.
Volatility Over Time: OPC's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | 930 | Huong Thi Pham | www.opcpharma.com |
OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicines in Vietnam and internationally. Its primary products include cardiovascular, nerve, nutrition, vitamins and minerals, respiratory system, urinary, musculoskeletal system, external use, digestion, endocrine, pain relief-inflammation, and others. The company also produces and trades in pharmaceutical products, materials, machinery, medical equipment, chemicals, cosmetics, functional foods, anti-malarial products, and food products; and alcoholic beverages, spirits, carbonated drinks, mineral water, and other beverages.
OPC Pharmaceutical Joint Stock Company Fundamentals Summary
| OPC fundamental statistics | |
|---|---|
| Market cap | ₫1.52t |
| Earnings (TTM) | ₫105.70b |
| Revenue (TTM) | ₫1.03t |
14.2x
P/E Ratio1.5x
P/S RatioIs OPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPC income statement (TTM) | |
|---|---|
| Revenue | ₫1.03t |
| Cost of Revenue | ₫531.69b |
| Gross Profit | ₫496.21b |
| Other Expenses | ₫390.51b |
| Earnings | ₫105.70b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.65k |
| Gross Margin | 48.27% |
| Net Profit Margin | 10.28% |
| Debt/Equity Ratio | 0% |
How did OPC perform over the long term?
See historical performance and comparison